knowledge -WSS

knowledge

author：knowledge 2025-09-27 10:46:21 - browse：63988

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Appeals court upholds limits to abortion pill

leisure time

WSS

After sickle

Leukemia patients are helped by Syndax's new type of therapy

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

In science, is the line between industry and academia shifting?

Radiology is caught between AI's potential and concern for patients

Winners, losers from Medicare’s list of drugs subject to price talks

hotspot

knowledge

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

How to make Best Hospitals ratings actually useful for patients

Anesthesiologist group: stop taking Ozempic before surgery

FDA approves world's first CRISPR

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Chemotherapy shortages won’t get better under Biden’s latest plan

The high cost of giving birth even with insurance

Teach medical students about patients with intellectual disabilities

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

AstraZeneca challenges Medicare drug negotiation program

focus

2024 GOP presidential candidates spar over abortion in debate

Pregnancy discrimination could be enabled by AI

How Long Island became the ‘eugenics capital of the world’

Diversity in medical illustrations gets boost from Chidiebere Ibe

What do new weight loss drugs mean for bariatric surgery?

Spinal cord stimulation reduces pain in amputees, study finds

entertainment

leisure time

knowledge

explore